“Good morning. Bill. Please. Step onto the scale. Touch the metal pads.” The device records an electrocardiogram from Bill’s fingers and – more importantly – circulation pulsing that makes his body subtly bob up and down on the scale. Machine learning tools compute that Bill’s heart failure symptoms have worsened.
This is how researchers at the Georgia Institute of Technology envision their experimental device reaching patients someday, and in a new study, they reported proof-of-concept success in recording and processing data from 43 patients with heart failure. A future marketable version of the medical monitoring scale would ideally notify a doctor, who would call Bill to adjust his medication at home, hopefully sparing him a long hospital stay and needless suffering.
The pulsing and bobbing signal is called a ballistocardiogram (BCG), a measurement researchers took more commonly about 100 years ago but gave up on as imaging technology far surpassed it. The researchers are making it useful again with modern computation.
“Our work is the first time that BCGs have been used to classify the status of heart failure patients,” said Omer Inan, the study’s principal investigator and an associate professor in Georgia Tech’s School of Electrical and Computer Engineering.
Heart failure affects 6.5 million Americans and is a slow-progressing disease, in which the heart works less and less effectively. Many people know it as congestive heart failure because a major symptom is fluid buildup, which can overwhelm the lungs, impeding breathing and possibly causing death.
Patients endure repeat hospitalizations to adjust medications when their condition dips, or “decompensates,” making heart failure a major driver of hospital admissions and healthcare costs. Home monitoring reduces hospitalizations but currently requires an invasive procedure.
Georgia Tech research was behind the launch of such an implantable heart failure home monitoring device in 2011. But this new solution would potentially dispense with the procedure, cost much less, and be much simpler to use – lowering patients’ resistance to home monitoring.
Given its early stage, the study’s BCG-EKG scale performed well in hospital tests but also in in-home tests, which was promising, since the solution principally targets eventual home use.
The research team, which included collaborators from the University of California, San Francisco, and Northwestern University, published their results in the journal IEEE Transactions on Biomedical Engineering. The research was funded by the National Heart, Lung and Blood Institute at the National Institutes of Health.
The EKG part of the experimental scale is not new nor its great diagnostic information, but it alone does not say enough about heart failure. The BCG part is mostly new, and it appears valuable to heart failure monitoring but also challenging to record and interpret.
“The ECG (EKG) has characteristic waves that clinicians have understood for 100 years, and now, computers read it a lot of the time,” Inan said. “Elements of the BCG signal aren’t really known well yet, and they haven’t been measured in patients with heart failure very much at all.”
The EKG is electrical; the body conducts its signals well, and the recordings are clear.
The BCG is a mechanical signal; body fat dampens it, and it faces a lot of interference in the body like tissue variations and muscle movement. BCGs are also noisier in people with cardiovascular disease.
Patients with heart failure tend to be feebler, and initially, the researchers worried they would wobble on scales during home tests, adding even more noise to the BCGs. But the recordings were very productive.
Though a BCG read-out is scribble compared to an EKG’s near-uniform etchings, BCGs have some patterns that parallel an EKG’s. For example, the big upward spike in an EKG is followed by the BCG’s big “J-wave.”
The researchers processed BCGs with three machine learning algorithms, revealing patterns that differ when a patient’s heart failure is compensated, that is, healthier, from when it is decompensated.
“In someone with decompensated heart failure, the cardiovascular system can no longer compensate for the reduced heart function, and then the flow of blood through the arteries is more disorderly, and we see it in the mechanical signal of the BCG,” Inan said. “That difference does not show up in the ECG because it’s an electrical signal.”
“The most important characteristic was the degree to which the BCG is variable, which would mean inconsistent blood flow. If you chop up the recording into 20-second intervals and the individual segments differ from each other a lot, that’s a good marker of decompensation,” Inan said.
The Latest on: Medical monitoring scale
via Google News
The Latest on: Medical monitoring scale
- BioIntelliSense Introduces the 5G-enabled BioHub Connectivity Gateway to Its Remote Patient Monitoring (RPM) Data Serviceon March 21, 2020 at 7:47 pm
BioIntelliSense offers a new standard for Remote Patient Monitoring (RPM) by combining an effortless patient experience with medical grade clinical accuracy and cost-effective ... postacute recovery ...
- Richardson Medical Center has first confirmed case of COVID-19on March 21, 2020 at 4:45 pm
Wide scale testing is a critical part of ... (AP Photo/John Minchillo) Since out noon post, Richardson Medical Center has received our first confirmed positive test result for COVID-19. The patient ...
- Blockchain Holdings Acquires Monitoring System, Successfully Implemented in Hong Kong, to Help Stem the Spread of COVID-19on March 20, 2020 at 4:00 pm
A Vancouver-based tech company has recently acquired an effective quarantine monitoring technology, now being used in Hong Kong ... hospital-style bracelet produced by an outsourced manufacturer, BCX ...
- Coronavirus pandemic: Private labs can scale up Covid-19 testing by 10x, but safety concerns remainon March 18, 2020 at 12:48 am
Despite best efforts, the government labs are only able to do 6,000 tests a day with a waiting period of two days.
- Indoor environmental quality and learning outcomes: protocol on large-scale sensor deployment in schoolson March 17, 2020 at 9:26 pm
Ethics and dissemination Medical Ethical Approval for the current study was waived by the Medical Ethical ... The height was chosen following current guidelines for air quality monitoring in ...
- Consortium of Medical Schools Led by Mount Sinai Fast-Tracking COVID-19 Detection Test Utilizing Fluidigm Microfluidics Technologyon March 16, 2020 at 5:34 am
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that a consortium of medical schools ...
- Wright Medical Group (OTCMKTS:GCVRZ) Given Media Impact Score of -4.40on March 13, 2020 at 11:09 pm
News coverage about Wright Medical Group (OTCMKTS:GCVRZ) has been trending extremely negative on Saturday, according to InfoTrie. The research firm rates the sentiment of media coverage by monitoring ...
- TempTraq® Ready to Support Remote Temperature Monitoring of Coronavirus Patientson March 10, 2020 at 1:20 pm
/PRNewswire/ -- With the rapid spread of the new coronavirus, COVID-19, monitoring temperatures of infected or exposed patients is a major focus for ...
- Nemaura Medical Enters Into Multiple Verbal Non-Binding Agreements for its sugarBEAT® Platformon March 10, 2020 at 4:04 am
Nemaura Medical, Inc. (NASDAQ: NMRD ... highly capable strategic partners as we seek to bring the first ever non-invasive continuous glucose monitoring system to market, is a key initiative for ...
via Bing News